Here are relevant reports on : photodynamic-therapy-market
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
The global viral vector manufacturing market, valued at US$4.8 billion in 2022, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 18.2% from 2023 to 2028, culminating in a forecasted valuation of US$12.8 billion by the end of the period. The growth of this market is majorly driven by g rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, and effectiveness of viral vectors in gene therapy delivery.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Patient Engagement Solutions Market by Therapy (Chronic [Obesity, Diabetes], Women’s Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient), Unmet Need, Investment - Forecast to 2030
The Asia Pacific Patient Engagement Solutions market, valued at USD 3.45 billion in 2024, stood at USD 3.97 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of USD 7.48 billion by the end of the period. This growth is driven by the rising demand for patient-centered and personalized care, a rapid expansion of telehealth and remote care frameworks, and more investments in digital healthcare infrastructure within the Asia Pacific region.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) - Global Forecast to 2022
The oxygen therapy equipment market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7% from 2017 to 2022. Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
US Patient Engagement Solutions Market by Therapy [Chronic (CVD, Diabetes), Women’s Health], Application (Home & Financial Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient) - Forecast to 2030
The US Patient Engagement Solutions market, valued at USD 12.86 billion in 2024, stood at USD 14.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of USD 25.01 billion by the end of the period. This growth is driven by increased adoption of digital health technologies, a shift toward value-based models and patient-centered care, the prevalence of chronic diseases, and greater use of smartphones, patient portals, and telehealth solutions.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare Market Outlook – [By Health Indicators (Life Expectancy, Mortality), Disease Burden (Epidemiology, Average Cost Of Therapy), Health System (Infrastructure, Expenditure), Regulatory Landscape] - Analysis & Forecast To 2020
The APAC region showcases diverse healthcare challenges across various countries. These range from improving healthcare access in developing countries of Vietnam to tackling rising diabetes, cancer, and cardiovascular diseases in well developed nations of Japan and Pacific countries. In addition, regions of China and India that lie in between developing and well developed countries are facing increase in diseases burden, problems of poverty, limited access to high quality treatment, and slow increase in disposable income. The APAC Healthcare Market Outlook examines the health indicators and healthcare system across India, China, Japan, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia, and New Zealand. The APAC Healthcare Market Outlook is segmented into five broad categories: health status, healthcare system assessment, healthcare regulatory landscape, medical devices infrastructure assessment, hospital chain assessment in top 10 hospitals.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cell Therapy Technologies Market by Product (Media, Sera, Reagents, Vessels, Equipment), Process (Expansion, Isolation, Characterization, Collection, Preservation, Distribution, QC), Type (T-cells, Stem Cells), Application (Cancer) - Global Forecast to 2030
The global cell therapy technologies market, valued at US$4.05 billion in 2024, stood at US$4.41 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$7.91 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030
Global negative pressure wound therapy market valued at $2.59B in 2024, reached $2.76B in 2025, and is projected to grow at a robust 6.9% CAGR, hitting $3.84B by 2030. The growth potential of emerging countries and cost effectiveness of negative pressure wound therapy products also poses an opportunistic factor for market growth.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Compression Therapy Market by Technique (Static, Dynamic), Product (Bandage, Wraps, Stockings, Tapes, Braces, Pneumatic), Application (Varicose Vein, DVT, Lymphedema, Ulcers), Distribution Channel (Clinics, Pharmacy, E-Commerce) - Global Forecasts to 2030
Global compression therapy market valued at $4.3B in 2024, reached $4.5B in 2025, and is projected to grow at a robust 5.5% CAGR, hitting $5.9B by 2030. The key factor driving the compression therapy market is the increasing prevalence of venous disorders and lymphedema, particularly among the elderly and post-surgical patients. Additionally, the rising rates of obesity and advancements in smart compression devices are further boosting demand in this market.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021
The global viral inactivation market is segmented on the basis of method, product, application, end user, and geography. By method, the market is divided into solvent detergent method, pasteurization, and other methods. The global viral inactivation market was valued at USD 320.5 Million in 2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021.
- Published: June 2016
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
